When HRT Isn't Working: Adjusting the Plan
SaveIf hormone therapy is not easing symptoms, the common reasons are a dose that is too low, variable absorption from a patch or gel, or symptoms that stem from something other than menopause. Adjusting the dose, route, or progestogen helps many people, and full effects can take several weeks to show.
Last updated: July 2026
Why might HRT not be working?
Several fixable factors explain why hormone therapy sometimes underdelivers. The dose may be too low for your symptoms, absorption from a patch or gel may be incomplete, or the particular progestogen may not suit you 1Ref 1The North American Menopause Society (Menopause Society) (2022).The 2022 Hormone Therapy Position Statement of The North American Menopause Society.Individualized dosing and route, variable transdermal absorption, titration to the lowest effective dose, and that hormone therapy is not first-line for depression.. Timing matters as well: hot flashes often ease within 2 to 4 weeks, but full benefit for sleep and mood can take 2 to 3 months 1Ref 1The North American Menopause Society (Menopause Society) (2022).The 2022 Hormone Therapy Position Statement of The North American Menopause Society.Individualized dosing and route, variable transdermal absorption, titration to the lowest effective dose, and that hormone therapy is not first-line for depression.. According to the North American Menopause Society, therapy is meant to be titrated to the lowest dose that controls symptoms, which frequently means adjusting after the first review 1Ref 1The North American Menopause Society (Menopause Society) (2022).The 2022 Hormone Therapy Position Statement of The North American Menopause Society.Individualized dosing and route, variable transdermal absorption, titration to the lowest effective dose, and that hormone therapy is not first-line for depression.. A comparative review by AHRQ confirmed that different menopause therapies vary in how well and how quickly they work 2Ref 2Grant MD, Marbella A, Wang AT, Pines E, Hoag J, Bonnell C, Ziegler KM, Aronson N (2015).Menopausal Symptoms: Comparative Effectiveness of Therapies (Comparative Effectiveness Review No. 147).Comparative effectiveness of therapies for menopausal symptoms, including differences in how well and how quickly options work..
Could the dose or absorption be too low?
A dose that looked reasonable on paper can still be too low for a given person. Absorption from transdermal patches and gels varies with skin type, application site, and how consistently they are used, so identical products can produce different blood levels 1Ref 1The North American Menopause Society (Menopause Society) (2022).The 2022 Hormone Therapy Position Statement of The North American Menopause Society.Individualized dosing and route, variable transdermal absorption, titration to the lowest effective dose, and that hormone therapy is not first-line for depression.. When symptoms persist despite steady use, a clinician may raise the dose, change the application site, or move from a gel to a patch 1Ref 1The North American Menopause Society (Menopause Society) (2022).The 2022 Hormone Therapy Position Statement of The North American Menopause Society.Individualized dosing and route, variable transdermal absorption, titration to the lowest effective dose, and that hormone therapy is not first-line for depression.. According to the North American Menopause Society, some people need higher transdermal doses to reach the estrogen levels that control hot flashes 1Ref 1The North American Menopause Society (Menopause Society) (2022).The 2022 Hormone Therapy Position Statement of The North American Menopause Society.Individualized dosing and route, variable transdermal absorption, titration to the lowest effective dose, and that hormone therapy is not first-line for depression.. Checking a blood estradiol level after about 6 weeks is occasionally useful when absorption is in doubt, though symptom relief usually guides the plan 1Ref 1The North American Menopause Society (Menopause Society) (2022).The 2022 Hormone Therapy Position Statement of The North American Menopause Society.Individualized dosing and route, variable transdermal absorption, titration to the lowest effective dose, and that hormone therapy is not first-line for depression..
When should you give a change more time?
Patience is part of getting hormone therapy right, because symptom relief and side effects follow different timelines. Vasomotor symptoms can take up to 12 weeks to respond fully to a new dose, so switching too soon risks abandoning a plan that would have worked 1Ref 1The North American Menopause Society (Menopause Society) (2022).The 2022 Hormone Therapy Position Statement of The North American Menopause Society.Individualized dosing and route, variable transdermal absorption, titration to the lowest effective dose, and that hormone therapy is not first-line for depression.. It also helps to have realistic expectations about how long symptoms last: the SWAN study found that hot flashes and night sweats persist for a median of 7.4 years, and longer for some women 3Ref 3Avis NE, Crawford SL, Greendale G, et al. / Study of Women's Health Across the Nation (SWAN) (2015).Duration of menopausal vasomotor symptoms over the menopause transition.SWAN cohort finding that vasomotor symptoms last a median of 7.4 years across the menopause transition.. Hormone therapy manages these symptoms rather than ending the underlying transition, so returning symptoms after a dose change are common and adjustable 1Ref 1The North American Menopause Society (Menopause Society) (2022).The 2022 Hormone Therapy Position Statement of The North American Menopause Society.Individualized dosing and route, variable transdermal absorption, titration to the lowest effective dose, and that hormone therapy is not first-line for depression.. A clinician can judge when to hold steady and when to change course 2Ref 2Grant MD, Marbella A, Wang AT, Pines E, Hoag J, Bonnell C, Ziegler KM, Aronson N (2015).Menopausal Symptoms: Comparative Effectiveness of Therapies (Comparative Effectiveness Review No. 147).Comparative effectiveness of therapies for menopausal symptoms, including differences in how well and how quickly options work..
Are your symptoms even from menopause?
Not every symptom that lingers on hormone therapy is caused by low estrogen. Fatigue, low mood, joint aches, and brain fog overlap with thyroid disease, iron deficiency, sleep disorders, and depression, any of which can persist regardless of the hormone dose 1Ref 1The North American Menopause Society (Menopause Society) (2022).The 2022 Hormone Therapy Position Statement of The North American Menopause Society.Individualized dosing and route, variable transdermal absorption, titration to the lowest effective dose, and that hormone therapy is not first-line for depression.. According to the North American Menopause Society, mood symptoms in particular may need their own treatment rather than more estrogen 4Ref 4The North American Menopause Society (Menopause Society) (2023).The 2023 nonhormone therapy position statement of The North American Menopause Society.Evidence-based non-hormonal options — cognitive behavioral therapy, certain antidepressants, and newer targeted medicines — for menopause symptoms including mood.. Persistent mood changes or new weight changes are worth exploring separately 4Ref 4The North American Menopause Society (Menopause Society) (2023).The 2023 nonhormone therapy position statement of The North American Menopause Society.Evidence-based non-hormonal options — cognitive behavioral therapy, certain antidepressants, and newer targeted medicines — for menopause symptoms including mood.. Non-hormonal options — including certain antidepressants, cognitive behavioral therapy, and newer targeted medicines — can add to or replace hormones when symptoms are only partly hormonal 4Ref 4The North American Menopause Society (Menopause Society) (2023).The 2023 nonhormone therapy position statement of The North American Menopause Society.Evidence-based non-hormonal options — cognitive behavioral therapy, certain antidepressants, and newer targeted medicines — for menopause symptoms including mood..
When an HRT dose review needs a gynecologist
A clinician turns "this isn't working" into a specific next step. Someone still troubled by hot flashes or poor sleep after a fair trial benefits from a structured review of dose, route, progestogen, and adherence 1Ref 1The North American Menopause Society (Menopause Society) (2022).The 2022 Hormone Therapy Position Statement of The North American Menopause Society.Individualized dosing and route, variable transdermal absorption, titration to the lowest effective dose, and that hormone therapy is not first-line for depression.. A gynecologist or menopause-experienced clinician can also test for other contributors and adjust hormone therapy or add a non-hormonal option 4Ref 4The North American Menopause Society (Menopause Society) (2023).The 2023 nonhormone therapy position statement of The North American Menopause Society.Evidence-based non-hormonal options — cognitive behavioral therapy, certain antidepressants, and newer targeted medicines — for menopause symptoms including mood.. Bringing a symptom diary and a list of what has and has not helped makes that review faster. Gale can help you prepare for that conversation.
Common questions
Related
Menopause & midlife
Pill or HRT in Perimenopause: Which Fits WhenMenopause & midlife
Menopause Mood: When HRT Helps, When SSRIs DoMenopause & midlife
Starting HRT After 60: The Timing Question
Say it back
How would you explain this to someone you love?
Two or three sentences, just as you’d say it. Gale reflects back what you focused on — a mirror, not a quiz.
When adjusting HRT needs clinician input
- —Symptoms that clearly worsen rather than improve after several weeks on hormone therapy are a reason to seek clinician review.
- —New or unscheduled bleeding while adjusting a dose or regimen is a reason to arrange evaluation.
- —Low mood that deepens, or loss of interest and hopelessness, is a reason to seek mental health support, and thoughts of self-harm are a reason to call or text 988.
- —Sudden breathlessness, chest pain, or a hot, swollen, painful calf can signal a blood clot and is a reason to seek urgent medical care.
This article is general health education, not medical advice. Adjusting the dose, route, or type of hormone therapy is a decision to make with a gynecologist or a menopause-experienced clinician who knows your full history.
References
- 1.The North American Menopause Society (Menopause Society) (2022). The 2022 Hormone Therapy Position Statement of The North American Menopause Society. Menopause. doi:10.1097/GME.0000000000002028 ✓Individualized dosing and route, variable transdermal absorption, titration to the lowest effective dose, and that hormone therapy is not first-line for depression.
- 2.Grant MD, Marbella A, Wang AT, Pines E, Hoag J, Bonnell C, Ziegler KM, Aronson N (2015). Menopausal Symptoms: Comparative Effectiveness of Therapies (Comparative Effectiveness Review No. 147). Agency for Healthcare Research and Quality (AHRQ). PMID 25905155 ✓Comparative effectiveness of therapies for menopausal symptoms, including differences in how well and how quickly options work.
- 3.Avis NE, Crawford SL, Greendale G, et al. / Study of Women's Health Across the Nation (SWAN) (2015). Duration of menopausal vasomotor symptoms over the menopause transition. JAMA Internal Medicine. doi:10.1001/jamainternmed.2014.8063 ✓SWAN cohort finding that vasomotor symptoms last a median of 7.4 years across the menopause transition.
- 4.The North American Menopause Society (Menopause Society) (2023). The 2023 nonhormone therapy position statement of The North American Menopause Society. Menopause. doi:10.1097/GME.0000000000002200 ✓Evidence-based non-hormonal options — cognitive behavioral therapy, certain antidepressants, and newer targeted medicines — for menopause symptoms including mood.
4 sources, numbered by first appearance. General health information, not medical advice. AI-assisted editorial content — every citation independently verified. Editorial policy